nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—melanoma	0.204	0.512	CbGaD
Levothyroxine—ABCB1—melanoma	0.195	0.488	CbGaD
Levothyroxine—SLCO1B3—Docetaxel—melanoma	0.105	0.299	CbGbCtD
Levothyroxine—ALB—Vemurafenib—melanoma	0.0977	0.278	CbGbCtD
Levothyroxine—CYP3A4—Temozolomide—melanoma	0.0559	0.159	CbGbCtD
Levothyroxine—ABCB1—Dactinomycin—melanoma	0.0339	0.0967	CbGbCtD
Levothyroxine—CYP3A4—Vemurafenib—melanoma	0.0306	0.0872	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—melanoma	0.0175	0.0499	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—melanoma	0.0105	0.0299	CbGbCtD
Levothyroxine—Infertility—Carmustine—melanoma	0.00442	0.0629	CcSEcCtD
Levothyroxine—Infertility—Temozolomide—melanoma	0.00427	0.0608	CcSEcCtD
Levothyroxine—SERPINA7—neck—melanoma	0.00405	0.109	CbGeAlD
Levothyroxine—THRB—neck—melanoma	0.0025	0.0673	CbGeAlD
Levothyroxine—THRA—neck—melanoma	0.0025	0.0673	CbGeAlD
Levothyroxine—SLC16A2—neck—melanoma	0.00227	0.061	CbGeAlD
Levothyroxine—TTR—neck—melanoma	0.00186	0.05	CbGeAlD
Levothyroxine—SLCO4C1—mammalian vulva—melanoma	0.00154	0.0414	CbGeAlD
Levothyroxine—SLC7A5—eye—melanoma	0.00142	0.0382	CbGeAlD
Levothyroxine—SLC7A5—retina—melanoma	0.00141	0.0379	CbGeAlD
Levothyroxine—TTR—eye—melanoma	0.00138	0.0372	CbGeAlD
Levothyroxine—TTR—retina—melanoma	0.00137	0.0369	CbGeAlD
Levothyroxine—Menstruation irregular—Docetaxel—melanoma	0.00134	0.0191	CcSEcCtD
Levothyroxine—Wheezing—Bleomycin—melanoma	0.00128	0.0183	CcSEcCtD
Levothyroxine—Weight decreased—Vemurafenib—melanoma	0.00124	0.0176	CcSEcCtD
Levothyroxine—SLC7A5—skin of body—melanoma	0.00124	0.0332	CbGeAlD
Levothyroxine—SLCO4A1—retina—melanoma	0.00123	0.0331	CbGeAlD
Levothyroxine—SLC7A5—mammalian vulva—melanoma	0.00113	0.0303	CbGeAlD
Levothyroxine—Disorientation—Bleomycin—melanoma	0.00107	0.0153	CcSEcCtD
Levothyroxine—THRB—head—melanoma	0.00106	0.0284	CbGeAlD
Levothyroxine—THRA—head—melanoma	0.00106	0.0284	CbGeAlD
Levothyroxine—Coma—Carmustine—melanoma	0.00105	0.015	CcSEcCtD
Levothyroxine—SLCO4A1—mammalian vulva—melanoma	0.000985	0.0265	CbGeAlD
Levothyroxine—Alopecia—Vemurafenib—melanoma	0.000968	0.0138	CcSEcCtD
Levothyroxine—SLC16A2—head—melanoma	0.000958	0.0257	CbGeAlD
Levothyroxine—SLCO1C1—head—melanoma	0.000879	0.0236	CbGeAlD
Levothyroxine—Arthralgia—Vemurafenib—melanoma	0.000812	0.0115	CcSEcCtD
Levothyroxine—SLC7A5—head—melanoma	0.000807	0.0217	CbGeAlD
Levothyroxine—Affect lability—Temozolomide—melanoma	0.000796	0.0113	CcSEcCtD
Levothyroxine—TTR—head—melanoma	0.000786	0.0211	CbGeAlD
Levothyroxine—Dysphagia—Dactinomycin—melanoma	0.000773	0.011	CcSEcCtD
Levothyroxine—Mood swings—Temozolomide—melanoma	0.000767	0.0109	CcSEcCtD
Levothyroxine—Dehydration—Temozolomide—melanoma	0.000752	0.0107	CcSEcCtD
Levothyroxine—Weight decreased—Bleomycin—melanoma	0.00075	0.0107	CcSEcCtD
Levothyroxine—THRB—lymph node—melanoma	0.00074	0.0199	CbGeAlD
Levothyroxine—THRA—lymph node—melanoma	0.00074	0.0199	CbGeAlD
Levothyroxine—Muscular weakness—Carmustine—melanoma	0.000738	0.0105	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Bleomycin—melanoma	0.000729	0.0104	CcSEcCtD
Levothyroxine—Myocardial infarction—Bleomycin—melanoma	0.000725	0.0103	CcSEcCtD
Levothyroxine—Dysphagia—Carmustine—melanoma	0.000724	0.0103	CcSEcCtD
Levothyroxine—Muscular weakness—Temozolomide—melanoma	0.000714	0.0102	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000709	0.0101	CcSEcCtD
Levothyroxine—SLCO4A1—head—melanoma	0.000705	0.0189	CbGeAlD
Levothyroxine—Dysphagia—Temozolomide—melanoma	0.000699	0.00995	CcSEcCtD
Levothyroxine—Sweating increased—Temozolomide—melanoma	0.000681	0.00969	CcSEcCtD
Levothyroxine—Fatigue—Vemurafenib—melanoma	0.000671	0.00955	CcSEcCtD
Levothyroxine—SLC16A2—lymph node—melanoma	0.000671	0.018	CbGeAlD
Levothyroxine—Weight decreased—Temozolomide—melanoma	0.000633	0.009	CcSEcCtD
Levothyroxine—Flushing—Bleomycin—melanoma	0.000616	0.00876	CcSEcCtD
Levothyroxine—SLCO1C1—lymph node—melanoma	0.000616	0.0165	CbGeAlD
Levothyroxine—Body temperature increased—Vemurafenib—melanoma	0.000615	0.00875	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Docetaxel—melanoma	0.000593	0.00844	CcSEcCtD
Levothyroxine—Alopecia—Bleomycin—melanoma	0.000586	0.00834	CcSEcCtD
Levothyroxine—Flushing—Dactinomycin—melanoma	0.000574	0.00817	CcSEcCtD
Levothyroxine—SLC7A5—lymph node—melanoma	0.000565	0.0152	CbGeAlD
Levothyroxine—ABCB1—blood vessel—melanoma	0.000559	0.015	CbGeAlD
Levothyroxine—Asthenia—Vemurafenib—melanoma	0.000558	0.00794	CcSEcCtD
Levothyroxine—Cardiac failure—Docetaxel—melanoma	0.000551	0.00785	CcSEcCtD
Levothyroxine—Pruritus—Vemurafenib—melanoma	0.000551	0.00783	CcSEcCtD
Levothyroxine—Alopecia—Dactinomycin—melanoma	0.000547	0.00778	CcSEcCtD
Levothyroxine—Flushing—Carmustine—melanoma	0.000538	0.00765	CcSEcCtD
Levothyroxine—Diarrhoea—Vemurafenib—melanoma	0.000532	0.00758	CcSEcCtD
Levothyroxine—Liotrix—ALB—melanoma	0.000524	0.296	CrCbGaD
Levothyroxine—Flushing—Temozolomide—melanoma	0.00052	0.00739	CcSEcCtD
Levothyroxine—Arrhythmia—Carmustine—melanoma	0.000517	0.00736	CcSEcCtD
Levothyroxine—Alopecia—Carmustine—melanoma	0.000512	0.00728	CcSEcCtD
Levothyroxine—SLCO1A2—head—melanoma	0.000505	0.0136	CbGeAlD
Levothyroxine—Dehydration—Docetaxel—melanoma	0.0005	0.00712	CcSEcCtD
Levothyroxine—Liotrix—ABCB1—melanoma	0.0005	0.282	CrCbGaD
Levothyroxine—Vomiting—Vemurafenib—melanoma	0.000495	0.00704	CcSEcCtD
Levothyroxine—Alopecia—Temozolomide—melanoma	0.000495	0.00704	CcSEcCtD
Levothyroxine—SLCO4A1—lymph node—melanoma	0.000493	0.0133	CbGeAlD
Levothyroxine—Rash—Vemurafenib—melanoma	0.000491	0.00698	CcSEcCtD
Levothyroxine—Dermatitis—Vemurafenib—melanoma	0.00049	0.00697	CcSEcCtD
Levothyroxine—Headache—Vemurafenib—melanoma	0.000487	0.00694	CcSEcCtD
Levothyroxine—Confusional state—Bleomycin—melanoma	0.000475	0.00676	CcSEcCtD
Levothyroxine—Tremor—Carmustine—melanoma	0.000472	0.00672	CcSEcCtD
Levothyroxine—Dysphagia—Docetaxel—melanoma	0.000465	0.00662	CcSEcCtD
Levothyroxine—Agitation—Carmustine—melanoma	0.000463	0.00659	CcSEcCtD
Levothyroxine—Nausea—Vemurafenib—melanoma	0.000462	0.00658	CcSEcCtD
Levothyroxine—Tremor—Temozolomide—melanoma	0.000457	0.0065	CcSEcCtD
Levothyroxine—Angina pectoris—Docetaxel—melanoma	0.000453	0.00645	CcSEcCtD
Levothyroxine—Agitation—Temozolomide—melanoma	0.000448	0.00637	CcSEcCtD
Levothyroxine—Angioedema—Temozolomide—melanoma	0.000445	0.00634	CcSEcCtD
Levothyroxine—Convulsion—Carmustine—melanoma	0.000437	0.00622	CcSEcCtD
Levothyroxine—Palpitations—Temozolomide—melanoma	0.000431	0.00613	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00043	0.00611	CcSEcCtD
Levothyroxine—Anxiety—Carmustine—melanoma	0.000428	0.00609	CcSEcCtD
Levothyroxine—Convulsion—Temozolomide—melanoma	0.000422	0.00601	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—melanoma	0.000421	0.00599	CcSEcCtD
Levothyroxine—Dyspnoea—Bleomycin—melanoma	0.00042	0.00598	CcSEcCtD
Levothyroxine—Confusional state—Carmustine—melanoma	0.000415	0.0059	CcSEcCtD
Levothyroxine—Arthralgia—Temozolomide—melanoma	0.000415	0.0059	CcSEcCtD
Levothyroxine—Anxiety—Temozolomide—melanoma	0.000413	0.00588	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Docetaxel—melanoma	0.000409	0.00582	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—melanoma	0.000406	0.00578	CcSEcCtD
Levothyroxine—Tachycardia—Carmustine—melanoma	0.000402	0.00571	CcSEcCtD
Levothyroxine—Confusional state—Temozolomide—melanoma	0.000401	0.00571	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000401	0.0057	CcSEcCtD
Levothyroxine—Feeling abnormal—Bleomycin—melanoma	0.000389	0.00553	CcSEcCtD
Levothyroxine—Hyperhidrosis—Temozolomide—melanoma	0.000384	0.00547	CcSEcCtD
Levothyroxine—Liothyronine—ALB—melanoma	0.000382	0.216	CrCbGaD
Levothyroxine—Fatigue—Dactinomycin—melanoma	0.000379	0.00539	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Carmustine—melanoma	0.000375	0.00533	CcSEcCtD
Levothyroxine—Urticaria—Bleomycin—melanoma	0.000375	0.00533	CcSEcCtD
Levothyroxine—Body temperature increased—Bleomycin—melanoma	0.000373	0.0053	CcSEcCtD
Levothyroxine—Insomnia—Carmustine—melanoma	0.000372	0.0053	CcSEcCtD
Levothyroxine—Dyspnoea—Carmustine—melanoma	0.000367	0.00522	CcSEcCtD
Levothyroxine—Liothyronine—ABCB1—melanoma	0.000365	0.206	CrCbGaD
Levothyroxine—Feeling abnormal—Dactinomycin—melanoma	0.000362	0.00516	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000362	0.00516	CcSEcCtD
Levothyroxine—Insomnia—Temozolomide—melanoma	0.00036	0.00512	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dactinomycin—melanoma	0.00036	0.00512	CcSEcCtD
Levothyroxine—Dyspnoea—Temozolomide—melanoma	0.000355	0.00504	CcSEcCtD
Levothyroxine—ALB—lymph node—melanoma	0.000351	0.00944	CbGeAlD
Levothyroxine—Body temperature increased—Dactinomycin—melanoma	0.000348	0.00495	CcSEcCtD
Levothyroxine—Abdominal pain—Dactinomycin—melanoma	0.000348	0.00495	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—melanoma	0.000345	0.00492	CcSEcCtD
Levothyroxine—Fatigue—Temozolomide—melanoma	0.000343	0.00488	CcSEcCtD
Levothyroxine—Feeling abnormal—Carmustine—melanoma	0.000339	0.00483	CcSEcCtD
Levothyroxine—Asthenia—Bleomycin—melanoma	0.000338	0.00481	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Carmustine—melanoma	0.000337	0.00479	CcSEcCtD
Levothyroxine—Pruritus—Bleomycin—melanoma	0.000334	0.00475	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—melanoma	0.000333	0.00473	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—melanoma	0.000329	0.00468	CcSEcCtD
Levothyroxine—Feeling abnormal—Temozolomide—melanoma	0.000328	0.00466	CcSEcCtD
Levothyroxine—Abdominal pain—Carmustine—melanoma	0.000325	0.00463	CcSEcCtD
Levothyroxine—Body temperature increased—Carmustine—melanoma	0.000325	0.00463	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Temozolomide—melanoma	0.000325	0.00463	CcSEcCtD
Levothyroxine—Urticaria—Temozolomide—melanoma	0.000316	0.0045	CcSEcCtD
Levothyroxine—Asthenia—Dactinomycin—melanoma	0.000315	0.00449	CcSEcCtD
Levothyroxine—Body temperature increased—Temozolomide—melanoma	0.000314	0.00447	CcSEcCtD
Levothyroxine—Abdominal pain—Temozolomide—melanoma	0.000314	0.00447	CcSEcCtD
Levothyroxine—Diarrhoea—Dactinomycin—melanoma	0.000301	0.00428	CcSEcCtD
Levothyroxine—Vomiting—Bleomycin—melanoma	0.0003	0.00427	CcSEcCtD
Levothyroxine—Rash—Bleomycin—melanoma	0.000297	0.00423	CcSEcCtD
Levothyroxine—Dermatitis—Bleomycin—melanoma	0.000297	0.00423	CcSEcCtD
Levothyroxine—Asthenia—Carmustine—melanoma	0.000295	0.0042	CcSEcCtD
Levothyroxine—ABCB1—retina—melanoma	0.000295	0.00793	CbGeAlD
Levothyroxine—Palpitations—Docetaxel—melanoma	0.000286	0.00407	CcSEcCtD
Levothyroxine—Asthenia—Temozolomide—melanoma	0.000285	0.00406	CcSEcCtD
Levothyroxine—Diarrhoea—Carmustine—melanoma	0.000282	0.00401	CcSEcCtD
Levothyroxine—Pruritus—Temozolomide—melanoma	0.000281	0.004	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—melanoma	0.000281	0.00399	CcSEcCtD
Levothyroxine—Nausea—Bleomycin—melanoma	0.00028	0.00398	CcSEcCtD
Levothyroxine—Vomiting—Dactinomycin—melanoma	0.00028	0.00398	CcSEcCtD
Levothyroxine—Rash—Dactinomycin—melanoma	0.000277	0.00394	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—melanoma	0.000276	0.00393	CcSEcCtD
Levothyroxine—Diarrhoea—Temozolomide—melanoma	0.000272	0.00387	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—melanoma	0.000267	0.00379	CcSEcCtD
Levothyroxine—Vomiting—Carmustine—melanoma	0.000262	0.00372	CcSEcCtD
Levothyroxine—Nausea—Dactinomycin—melanoma	0.000261	0.00372	CcSEcCtD
Levothyroxine—Shock—Docetaxel—melanoma	0.00026	0.0037	CcSEcCtD
Levothyroxine—Rash—Carmustine—melanoma	0.000259	0.00369	CcSEcCtD
Levothyroxine—Dermatitis—Carmustine—melanoma	0.000259	0.00369	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—melanoma	0.000258	0.00367	CcSEcCtD
Levothyroxine—Headache—Carmustine—melanoma	0.000258	0.00367	CcSEcCtD
Levothyroxine—Vomiting—Temozolomide—melanoma	0.000253	0.0036	CcSEcCtD
Levothyroxine—Rash—Temozolomide—melanoma	0.000251	0.00357	CcSEcCtD
Levothyroxine—Dermatitis—Temozolomide—melanoma	0.000251	0.00356	CcSEcCtD
Levothyroxine—Headache—Temozolomide—melanoma	0.000249	0.00354	CcSEcCtD
Levothyroxine—Nausea—Carmustine—melanoma	0.000244	0.00348	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000241	0.00343	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—melanoma	0.000239	0.0034	CcSEcCtD
Levothyroxine—ABCB1—mammalian vulva—melanoma	0.000236	0.00635	CbGeAlD
Levothyroxine—Nausea—Temozolomide—melanoma	0.000236	0.00336	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—melanoma	0.000236	0.00335	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—melanoma	0.000228	0.00324	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—melanoma	0.000218	0.0031	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—melanoma	0.000216	0.00308	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—melanoma	0.000209	0.00297	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—melanoma	0.000209	0.00297	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—melanoma	0.00019	0.0027	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—melanoma	0.000187	0.00266	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—melanoma	0.000181	0.00257	CcSEcCtD
Levothyroxine—ABCB1—head—melanoma	0.000169	0.00454	CbGeAlD
Levothyroxine—Vomiting—Docetaxel—melanoma	0.000168	0.00239	CcSEcCtD
Levothyroxine—Rash—Docetaxel—melanoma	0.000167	0.00237	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—melanoma	0.000167	0.00237	CcSEcCtD
Levothyroxine—Headache—Docetaxel—melanoma	0.000166	0.00236	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—melanoma	0.000157	0.00224	CcSEcCtD
Levothyroxine—ABCB1—lymph node—melanoma	0.000118	0.00318	CbGeAlD
Levothyroxine—ALB—Metabolism—SDHD—melanoma	1.76e-05	0.000125	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.75e-05	0.000125	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC5A5—melanoma	1.75e-05	0.000124	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ITGB3—melanoma	1.73e-05	0.000123	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PRKCA—melanoma	1.73e-05	0.000123	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.71e-05	0.000122	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPAM—melanoma	1.71e-05	0.000122	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.71e-05	0.000122	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAP2K1—melanoma	1.71e-05	0.000121	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPAM—melanoma	1.7e-05	0.000121	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.7e-05	0.000121	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CD—melanoma	1.7e-05	0.000121	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CD44—melanoma	1.69e-05	0.00012	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GNAQ—melanoma	1.69e-05	0.00012	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.67e-05	0.000119	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PHGDH—melanoma	1.66e-05	0.000118	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LUM—melanoma	1.66e-05	0.000118	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HS3ST5—melanoma	1.65e-05	0.000117	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.65e-05	0.000117	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.64e-05	0.000116	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—melanoma	1.63e-05	0.000116	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—melanoma	1.63e-05	0.000116	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPSE—melanoma	1.62e-05	0.000116	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.62e-05	0.000115	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—FGF2—melanoma	1.62e-05	0.000115	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1B1—melanoma	1.62e-05	0.000115	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAC1—melanoma	1.6e-05	0.000114	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CUBN—melanoma	1.59e-05	0.000113	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—melanoma	1.59e-05	0.000113	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—melanoma	1.59e-05	0.000113	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.57e-05	0.000112	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK3—melanoma	1.56e-05	0.000111	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ABCB1—melanoma	1.56e-05	0.000111	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MMP1—melanoma	1.55e-05	0.00011	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SDHD—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BSG—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CSPG4—melanoma	1.54e-05	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CDK2—melanoma	1.52e-05	0.000108	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MDM2—melanoma	1.52e-05	0.000108	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—melanoma	1.52e-05	0.000108	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.5e-05	0.000107	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—melanoma	1.5e-05	0.000106	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPAM—melanoma	1.49e-05	0.000106	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.48e-05	0.000106	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK1—melanoma	1.48e-05	0.000105	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—melanoma	1.48e-05	0.000105	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CB—melanoma	1.48e-05	0.000105	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.46e-05	0.000104	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PLA2G6—melanoma	1.46e-05	0.000104	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PLA2G6—melanoma	1.45e-05	0.000103	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PRKCA—melanoma	1.43e-05	0.000102	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CG—melanoma	1.43e-05	0.000102	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.43e-05	0.000101	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.42e-05	0.000101	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ERCC2—melanoma	1.42e-05	0.000101	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—melanoma	1.42e-05	0.000101	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—FN1—melanoma	1.41e-05	0.0001	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.41e-05	0.0001	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—melanoma	1.4e-05	9.96e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS2—melanoma	1.4e-05	9.93e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.39e-05	9.89e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.39e-05	9.88e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1B—melanoma	1.39e-05	9.86e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—melanoma	1.38e-05	9.8e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CASP3—melanoma	1.36e-05	9.66e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—melanoma	1.36e-05	9.65e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—melanoma	1.35e-05	9.61e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EGF—melanoma	1.34e-05	9.5e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ABCB1—melanoma	1.33e-05	9.46e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.32e-05	9.41e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—melanoma	1.32e-05	9.41e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.31e-05	9.34e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—melanoma	1.31e-05	9.32e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—VCAN—melanoma	1.31e-05	9.3e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—VCAN—melanoma	1.3e-05	9.25e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—melanoma	1.29e-05	9.15e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—melanoma	1.28e-05	9.13e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—melanoma	1.28e-05	9.1e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—melanoma	1.28e-05	9.08e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NFKB1—melanoma	1.27e-05	9.04e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PLA2G6—melanoma	1.27e-05	9.02e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CD—melanoma	1.26e-05	8.93e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLCB4—melanoma	1.25e-05	8.9e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—melanoma	1.24e-05	8.81e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.24e-05	8.8e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IGF1—melanoma	1.24e-05	8.8e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.23e-05	8.75e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.23e-05	8.71e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PRKCA—melanoma	1.22e-05	8.71e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ERCC2—melanoma	1.21e-05	8.64e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.21e-05	8.58e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.19e-05	8.5e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—melanoma	1.19e-05	8.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CD—melanoma	1.19e-05	8.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.19e-05	8.45e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC6A11—melanoma	1.18e-05	8.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.18e-05	8.37e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.18e-05	8.37e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.17e-05	8.3e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—melanoma	1.15e-05	8.2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTAP—melanoma	1.15e-05	8.14e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—melanoma	1.14e-05	8.12e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—VCAN—melanoma	1.14e-05	8.1e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—melanoma	1.14e-05	8.1e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—melanoma	1.14e-05	8.1e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—melanoma	1.12e-05	7.98e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP17A1—melanoma	1.1e-05	7.85e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP17A1—melanoma	1.1e-05	7.8e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—melanoma	1.09e-05	7.78e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—melanoma	1.09e-05	7.76e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.09e-05	7.74e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—melanoma	1.08e-05	7.71e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—melanoma	1.08e-05	7.7e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.08e-05	7.69e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.07e-05	7.64e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—melanoma	1.06e-05	7.55e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—melanoma	1.05e-05	7.47e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GNA11—melanoma	1.04e-05	7.41e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK1—melanoma	1.04e-05	7.38e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—melanoma	1.04e-05	7.38e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GNA11—melanoma	1.04e-05	7.37e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—melanoma	1.04e-05	7.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LUM—melanoma	1.02e-05	7.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PHGDH—melanoma	1.02e-05	7.26e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—FASN—melanoma	1.02e-05	7.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—FASN—melanoma	1.01e-05	7.21e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.01e-05	7.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—melanoma	1e-05	7.13e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPSE—melanoma	1e-05	7.12e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1e-05	7.12e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—melanoma	9.97e-06	7.09e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—melanoma	9.86e-06	7.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.86e-06	7.01e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CUBN—melanoma	9.83e-06	6.99e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—melanoma	9.8e-06	6.97e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—melanoma	9.74e-06	6.92e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GNAQ—melanoma	9.69e-06	6.89e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD44—melanoma	9.69e-06	6.89e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GNAQ—melanoma	9.63e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD44—melanoma	9.63e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP17A1—melanoma	9.61e-06	6.84e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—melanoma	9.59e-06	6.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—melanoma	9.51e-06	6.77e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SDHD—melanoma	9.49e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CSPG4—melanoma	9.49e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BSG—melanoma	9.49e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.49e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—melanoma	9.46e-06	6.72e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.43e-06	6.71e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.4e-06	6.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.35e-06	6.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1B1—melanoma	9.29e-06	6.6e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—melanoma	9.26e-06	6.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1B1—melanoma	9.23e-06	6.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPAM—melanoma	9.19e-06	6.54e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GNA11—melanoma	9.08e-06	6.46e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—melanoma	9.01e-06	6.41e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.9e-06	6.33e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—FASN—melanoma	8.88e-06	6.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—melanoma	8.74e-06	6.21e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—melanoma	8.71e-06	6.2e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—melanoma	8.6e-06	6.11e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—melanoma	8.52e-06	6.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GNAQ—melanoma	8.44e-06	6e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD44—melanoma	8.44e-06	6e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—melanoma	8.43e-06	6e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—melanoma	8.33e-06	5.93e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—melanoma	8.33e-06	5.92e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.2e-06	5.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.15e-06	5.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1B1—melanoma	8.09e-06	5.75e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—melanoma	8.09e-06	5.75e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—melanoma	7.99e-06	5.68e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—melanoma	7.98e-06	5.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLA2G6—melanoma	7.82e-06	5.56e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—melanoma	7.65e-06	5.44e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—melanoma	7.65e-06	5.44e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—melanoma	7.6e-06	5.41e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—melanoma	7.43e-06	5.28e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—melanoma	7.36e-06	5.23e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—melanoma	7.35e-06	5.23e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—melanoma	7.28e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK1—melanoma	7.28e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PRKCA—melanoma	7.04e-06	5.01e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—VCAN—melanoma	7.02e-06	4.99e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PRKCA—melanoma	7e-06	4.98e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—melanoma	6.98e-06	4.96e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—melanoma	6.94e-06	4.94e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—melanoma	6.87e-06	4.89e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—melanoma	6.67e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—melanoma	6.35e-06	4.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—melanoma	6.32e-06	4.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PRKCA—melanoma	6.13e-06	4.36e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—melanoma	6.11e-06	4.34e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—melanoma	6.08e-06	4.32e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP17A1—melanoma	5.92e-06	4.21e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—melanoma	5.84e-06	4.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.78e-06	4.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.75e-06	4.09e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GNA11—melanoma	5.59e-06	3.98e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—melanoma	5.51e-06	3.92e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—melanoma	5.48e-06	3.9e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FASN—melanoma	5.47e-06	3.89e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—melanoma	5.45e-06	3.87e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—melanoma	5.38e-06	3.83e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—melanoma	5.32e-06	3.78e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—melanoma	5.29e-06	3.76e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—melanoma	5.24e-06	3.73e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GNAQ—melanoma	5.2e-06	3.7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD44—melanoma	5.2e-06	3.7e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—melanoma	5.16e-06	3.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1B1—melanoma	4.99e-06	3.54e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—melanoma	4.85e-06	3.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—melanoma	4.82e-06	3.43e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—melanoma	4.8e-06	3.42e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—melanoma	4.78e-06	3.4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—melanoma	4.64e-06	3.3e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—melanoma	4.48e-06	3.19e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—melanoma	4.28e-06	3.04e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—melanoma	4.22e-06	3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—melanoma	4.22e-06	3e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—melanoma	4.2e-06	2.99e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—melanoma	4.19e-06	2.98e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—melanoma	4.17e-06	2.96e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—melanoma	4.16e-06	2.96e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—melanoma	4.11e-06	2.92e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PRKCA—melanoma	3.78e-06	2.69e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—melanoma	3.75e-06	2.66e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—melanoma	3.68e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—melanoma	3.66e-06	2.6e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—melanoma	3.65e-06	2.6e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—melanoma	3.65e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—melanoma	3.63e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—melanoma	3.18e-06	2.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—melanoma	2.96e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—melanoma	2.86e-06	2.03e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—melanoma	2.6e-06	1.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—melanoma	2.58e-06	1.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—melanoma	2.57e-06	1.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—melanoma	2.56e-06	1.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—melanoma	2.27e-06	1.61e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—melanoma	2.25e-06	1.6e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—melanoma	2.24e-06	1.6e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—melanoma	2.1e-06	1.5e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—melanoma	2.09e-06	1.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—melanoma	1.96e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—melanoma	1.83e-06	1.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—melanoma	1.38e-06	9.83e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—melanoma	1.13e-06	8.03e-06	CbGpPWpGaD
